Drugs / DLBS1442
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01942122 | Oct 2015 → Feb 2021 | ovarian endometriosis | Dexa Medica Group | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DLBS1442 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01942122 ↗ |